SSR4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.108000E-01
Normal-vs-Stage2
1.389160E-01
Normal-vs-Stage3
7.993800E-02
Normal-vs-Stage4
1.176150E-01
Stage1-vs-Stage2
3.323200E-01
Stage1-vs-Stage3
3.612800E-01
Stage1-vs-Stage4
2.745600E-01
Stage2-vs-Stage3
7.863000E-01
Stage2-vs-Stage4
5.396300E-02
Stage3-vs-Stage4
2.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.280400E-01
Normal-vs-AfricanAmerican
8.116100E-02
Normal-vs-Asian
1.767020E-01
Caucasian-vs-AfricanAmerican
9.311000E-01
Caucasian-vs-Asian
5.040000E-01
AfricanAmerican-vs-Asian
5.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.484200E-01
Normal-vs-Female
3.637000E-01
Male-vs-Female
5.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.825000E-01
Normal-vs-Age(41-60Yrs)
4.264800E-01
Normal-vs-Age(61-80Yrs)
1.298970E-01
Normal-vs-Age(81-100Yrs)
3.943900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.815400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.704400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.535200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.601000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.382000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.011390E-01
Normal-vs-Daily Drinker
2.013800E-01
Normal-vs-Weekly Drinker
2.135600E-01
Normal-vs-Occasional Drinker
5.936300E-02
Normal-vs-Social Drinker
1.260820E-01
Non Drinker-vs-Daily Drinker
4.917800E-01
Non Drinker-vs-Weekly Drinker
6.232600E-01
Non Drinker-vs-Occasional Drinker
5.436200E-01
Non Drinker-vs-Social Drinker
5.965200E-01
Daily Drinker-vs-Weekly Drinker
8.810800E-01
Daily Drinker-vs-Occasional Drinker
8.431000E-01
Daily Drinker-vs-Social Drinker
8.254400E-01
Weekly Drinker-vs-Occasional Drinker
7.679400E-01
Weekly Drinker-vs-Social Drinker
7.651800E-01
Occasional Drinker-vs-Social Drinker
9.541000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.296000E-01
Normal-vs-Grade 2
9.240900E-03
Normal-vs-Grade 3
1.54289999999557E-05
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.069500E-02
Grade 1-vs-Grade 3
7.540900E-03
Grade 1-vs-Grade 4
8.296000E-01
Grade 2-vs-Grade 3
3.013800E-02
Grade 2-vs-Grade 4
9.240900E-03
Grade 3-vs-Grade 4
1.54289999999557E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.567000E-01
Normal-vs-NonDiabetic
3.077200E-01
Diabetic-vs-NonDiabetic
6.234600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.064200E-01
Normal-vs-NoPancreatitis
3.308600E-01
Pancreatitis-vs-NoPancreatitis
3.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.523400E-01
Normal-vs-N1
1.308820E-01
N0-vs-N1
4.322400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.068300E-02
Normal-vs-TP53-NonMutant
3.9218000000063E-05
TP53-Mutant-vs-TP53-NonMutant
3.353600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
